Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial.
Gershlick A, De Scheerder I, Chevalier B, Stephens-Lloyd A, Camenzind E, Vrints C, Reifart N, Missault L, Goy JJ, Brinker JA, Raizner AE, Urban P, Heldman AW. Gershlick A, et al. Among authors: chevalier b. Circulation. 2004 Feb 3;109(4):487-93. doi: 10.1161/01.CIR.0000109694.58299.A0. Epub 2004 Jan 26. Circulation. 2004. PMID: 14744971 Clinical Trial.
Comparison of neointimal formation in polymer-free paclitaxel stents versus stainless stents (from the ASPECT and ELUTES randomized clinical trials).
Kałuza GL, Gershlick AH, Park SJ, De Scheerder I, Chevalier B, Camenzind E, Goy JJ, Missault L, Reifart N, Vrints C, Urban P, Shim WH, Ho DS, Fearnot NE, Voorhees WD 3rd, Raizner AE. Kałuza GL, et al. Among authors: chevalier b. Am J Cardiol. 2004 Jul 15;94(2):199-201. doi: 10.1016/j.amjcard.2004.03.063. Am J Cardiol. 2004. PMID: 15246901
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial.
Chevalier B, Di Mario C, Neumann FJ, Ribichini F, Urban P, Popma JJ, Fitzgerald PJ, Cutlip DE, Williams DO, Ormiston J, Grube E, Whitbourn R, Schwartz LB; ZoMaxx I Investigators. Chevalier B, et al. JACC Cardiovasc Interv. 2008 Oct;1(5):524-32. doi: 10.1016/j.jcin.2008.08.010. JACC Cardiovasc Interv. 2008. PMID: 19463354 Free article. Clinical Trial.
Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
Chevalier B, Silber S, Park SJ, Garcia E, Schuler G, Suryapranata H, Koolen J, Hauptmann KE, Wijns W, Morice MC, Carrie D, van Es GA, Nagai H, Detiege D, Paunovic D, Serruys PW; NOBORI 1 Clinical Investigators. Chevalier B, et al. Circ Cardiovasc Interv. 2009 Jun;2(3):188-95. doi: 10.1161/CIRCINTERVENTIONS.108.823443. Epub 2009 May 8. Circ Cardiovasc Interv. 2009. PMID: 20031715 Clinical Trial.
Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials.
Waseda K, Hasegawa T, Ako J, Honda Y, Grube E, Whitbourn R, Ormiston J, O'Shaughnessy CD, Henry TD, Overlie P, Schwartz LB, Sudhir K, Chevalier B, Gray WA, Yeung AC, Fitzgerald PJ; ZoMaxx I and II Trial Investigators. Waseda K, et al. Among authors: chevalier b. Circ J. 2010 Nov;74(11):2334-9. doi: 10.1253/circj.cj-09-0850. Epub 2010 Sep 28. Circ J. 2010. PMID: 20890052 Free article.
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Miquel-Hebert K, Rapoza R, García-García HM. Serruys PW, et al. Among authors: chevalier b. Circulation. 2010 Nov 30;122(22):2301-12. doi: 10.1161/CIRCULATIONAHA.110.970772. Epub 2010 Nov 15. Circulation. 2010. PMID: 21098436
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study.
Danzi GB, Chevalier B, Urban P, Fath-Ordoubadi F, Carrie D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez JG, Sagic D, Laanmets P, Strupp G, West N, Paunovic D; NOBORI 2 Investigators. Danzi GB, et al. Among authors: chevalier b. EuroIntervention. 2012 May 15;8(1):109-16. doi: 10.4244/EIJV8I1A17. EuroIntervention. 2012. PMID: 22278136 Free article.
Why are we still using coronary bare-metal stents?
Morice MC, Urban P, Greene S, Schuler G, Chevalier B. Morice MC, et al. Among authors: chevalier b. J Am Coll Cardiol. 2013 Mar 12;61(10):1122-3. doi: 10.1016/j.jacc.2012.11.049. Epub 2013 Jan 16. J Am Coll Cardiol. 2013. PMID: 23333139 Free article. No abstract available.
Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy.
Urban P, Abizaid A, Chevalier B, Greene S, Meredith I, Morice MC, Pocock S. Urban P, et al. Among authors: chevalier b. Am Heart J. 2013 May;165(5):704-9. doi: 10.1016/j.ahj.2013.01.008. Epub 2013 Feb 19. Am Heart J. 2013. PMID: 23622906 Clinical Trial.
481 results